Artificial intelligence to guide precision anticancer therapy with multitargeted kinase inhibitors

Artificial intelligence to guide precision anticancer therapy with multitargeted kinase inhibitors

Abstract Background Vast amounts of rapidly accumulating biological data related to cancer and a remarkable progress in the field of artificial intelligence (AI) have paved the way for precision oncology. Our recent contribution to this area of research is CancerOmicsNet, an AI-based system to predi...

Full description

Bibliographic Details
Main Authors: Manali Singha, Limeng Pu, Brent A. Stanfield, Ifeanyi K. Uche, Paul J. F. Rider, Konstantin G. Kousoulas, J. Ramanujam, Michal Brylinski
Format: Article
Language:English
Published: BMC 2022-11-01
Series:BMC Cancer
Subjects:
Precision oncology
Cancer growth rate
Kinase inhibitors
Differential gene expression
Gene-disease association
Cancer-specific networks
Online Access:https://doi.org/10.1186/s12885-022-10293-0

Internet

https://doi.org/10.1186/s12885-022-10293-0

Similar Items